A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette.
Shoumariyeh K, Schneider N, Poggio T, Veratti P, Ehrenfeld S, Redhaber DM, Khan R, Pfeifer D, Klingeberg C, Kreutmair S, Rudelius M, Quintanilla-Martinez L, Fend F, Illert AL, Duyster J, Miething C
Oncogene. 2020 Feb;39(9):1904-1913. doi: 10.1038/s41388-019-1058-1. Epub 2019 Nov 21. PubMed Article
Shoumariyeh K, Schneider N, Poggio T, Veratti P, Ehrenfeld S, Redhaber DM, Khan R, Pfeifer D, Klingeberg C, Kreutmair S, Rudelius M, Quintanilla-Martinez L, Fend F, Illert AL, Duyster J, Miething C
Oncogene. 2020 Feb;39(9):1904-1913. doi: 10.1038/s41388-019-1058-1. Epub 2019 Nov 21. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 154469 | MSCV-Stop-EGFP (MSE) | MSCV-Stop-EGFP-pgk-Neo (retroviral construct containing the RFP-based translational stop cassette) |
| 154470 | MSCV-Stop-NPM-ALK-MSNA-IRES-EGFP (MSNAIE) | cDNA of NPM-ALK in the MSE backbone |